EU REACH Annex XIV Authorisation List Updated to Contain 59 Entries by Adding Five Entries
On 11 April 2022, the European Commission has published Commission Regulation (EU) 2022/586 to amend Annex XIV to REACH Regulation (EC) No 1907/2006. It shall enter into force on 1 May 2022. Five new substances shall be newly added to Annex XIV, as following:
Entries 55-59 shall be added in the table in Annex XIV:
| Entry No. |
Substance |
Intrinsic property(ies) referred to in Article 57 |
Latest application date |
Sunset date |
| 55 |
Tetraethyllead
EC No: 201-075-4
CAS No: 78-00-2 |
Toxic for reproduction (category 1A) |
1 November 2023 |
1 May 2025 |
| 56 |
4,4'-bis(dimethylamino)-4''-(methylamino)trityl alcohol (with ≥ 0.1% of Michler's ketone (EC No 202-027-5) or Michler's base (EC No 202-959-2))
EC No: 209-218-2
CAS No: 561-41-1 |
Carcinogenic (category 1B) |
1 November 2023 |
1 May 2025 |
| 57 |
Reaction products of 1,3,4-thiadiazolidine-2,5-dithione, formaldehyde and 4-heptylphenol, branched and linear (RP-HP) (with ≥ 0.1% w/w 4-heptylphenol, branched and linear)
EC No: -
CAS No: - |
Endocrine disrupting properties (Article 57, point (f) - environment) |
1 November 2023 |
1 May 2025 |
| 58 |
2-ethylhexyl 10-ethyl-4,4-dioctyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate (DOTE)
EC No: 239-622-4
CAS No: 15571-58-1 |
Toxic for reproduction (category 1B) |
1 November 2023 |
1 May 2025 |
| 59 |
Reaction mass of 2-ethylhexyl 10-ethyl-4,4-dioctyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate and 2-ethylhexyl 10-ethyl-4-[[2-[(2-ethylhexyl)oxy]-2-oxoethyl]thio]-4-octyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate (reaction mass of DOTE and MOTE)
EC No: -
CAS No: - |
Toxic for reproduction (category 1B) |
1 November 2023 |
1 May 2025 |
The placing on the market and the use of those substances in the EU will only be possible, from sunset date (i.e. the date from which the placing on the market and the use of the substance shall be prohibited unless an authorisation is granted), for those operators who have been granted an authorisation, and for those who have submitted an application for authorisation before the latest application date but a decision has not yet been adopted.
Note: Annex XIV - List of substances subject to authorization
About Intertek
Intertek is a leading Total Quality Assurance provider to industries worldwide. Our network of more than 1,000 laboratories and offices and more than 100 countries, delivers innovative and bespoke Assurance, Testing, Inspection and Certification solutions for our customers’ operations and supply chains. Intertek Total Quality Assurance expertise, delivered consistently with precision, pace and passion, enabling our customers to power ahead safely.
www.intertek.com.cn
中文
